Pharma contract Manufacturer in India | Industry experts
India is renowned for its cheap vaccines and generic medicines. India produces the third-most pharmaceuticals by volume and the fourteenth-most by value. India has the most US-FDA-compliant pharma plants outside the US, with over 10,000 pharmaceutical manufacturing facilities and 3,000 generic pharmaceutical companies making up the domestic pharmaceutical sector. The domestic pharmaceutical industry in India is anticipated to grow to US$ 65 billion by 2024 and US$ 120–130 billion by 2030. By 2030, the market for pharmaceutical equipment is projected to be worth $50 billion, expanding at a 15% CAGR.
India has 60,000 generic names in 60 therapeutic areas. Generic, OTC, API/Bulk, Vaccines, Contract Research & Manufacturing, Biosimilars, and Biologics dominate.
200 countries buy Indian drugs. India provided 50% of global vaccines, 40% of US generics, and 25% of UK medicine.
About 35% of the market is comprised of active pharmaceutical ingredients, or API. With an 8% market share in the global API industry, India ranks third in terms of API manufacturing.
Building on the traditional expertise in ayurvedic formulation, several herbal product manufacturers have flourished in recent times.
Industry Experts Pvt. Ltd. is at a critical junction point in this evolution. We have the expertise to connect you with established pharma contract manufacturing companies or assist you in setting up your own production unit in India.

Comments
Post a Comment